Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Emergence Agitation in Nasal Surgery
NCT06887998Phase 3Not yet recruiting
- Sponsor
- Cairo University
- Start
- Mar 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gabapentin in Emergence agitation (EA), sponsored by Cairo University. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
gabapentin
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT06887998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06887998.